Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

QLogic Reports 3Q Prelim Results

by Zacks Equity Research

January 16, 2013 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

QLogic ( QLGC - Analyst Report ) announced preliminary third quarter results on January 15, 2013. For the quarter ended December 30, 2012, the company expects to report GAAP earnings per share (“EPS”) in the range of 14 cents to 15 cents.

Excluding stock-based compensation, acquisition related charges and related tax effect, the company expects EPS to be in the range of 19 cents to 20 cents, significantly higher than its previously forecasted range of 14 cents to 19 cents. However, EPS is likely to decline significantly from 34 cents reported in the year-ago quarter but rise slightly from 18 cents reported in the previous quarter.

QLogic expects net revenue of approximately $119.0 million, slightly higher than its previously forecasted range of $112.0 million to $118.0 million. Revenue is expected to beat the Zacks Consensus Estimate of $115.0 million driven by strong performance from Host Products and Network products business segment.

However, third quarter estimated revenue declines significantly from $142.8 million reported in the year-ago quarter and remains flat sequentially. We believe that this shrinking revenue growth continues to reflect declining enterprise data center spending and sluggish macro-economic environment.

We note that QLogic has outperformed the Zacks Consensus Estimate by an average of 16.3% over the trailing four quarters. Although the Zacks Consensus Estimate was revised down by 7 cents over the last 90 days, QLogic’s preliminary result suggests another beat is on the cards.

Currently, the Zacks Consensus Estimate is pegged at 9 cents per share for the third quarter. Our pro forma calculations differ from management’s presentation as we exclude acquisition-related costs but include stock-based compensation expense and related tax effect.

Despite the imminent earnings beat, we prefer to remain cautious on the stock due to its lackluster margin outlook. Previously, QLogic had forecasted gross margin to be approximately 57.0% to 58.0% for the third quarter. This reflects a significant contraction from 68.5% reported in the year-ago quarter and 67.6% in the previous quarter.

The company also intends to spend approximately $60.0 million on operating expenses. We believe that increasing investments on engineering and stiff competition from peers such as Mellanox ( MLNX - Snapshot Report ) and Emulex ( ELX - Snapshot Report ) will hurt profitability going forward.

Currently, QLogic has a Zacks Rank #4 (Sell).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.